BioStem Technologies (BSEM) Competitor Comparison
We are evaluating the key criteria listed to compare BioStem Technologies (BSEM) against its competitors in the Biotechnology industry.
Market Capitalization
259 / 368Gross Profits
106 / 278Total Revenue
197 / 300EBITDA
53 / 337Free Cashflow
0 / 352Quick Ratio
347 / 357Earnings per Share
110 / 359Dividend yield
0 / 6Total Cash
357 / 358Performance 3 years
1 / 368Performance 5 years
4 / 368Performance 10 years
14 / 368Linearity 3 years
361 / 368Linearity 5 years
336 / 368Linearity 10 years
328 / 368Total Rank
262 / 368Dividend Rank
67 / 368Valuation Rank
95 / 368Piotroski Rank
52 / 368Muliplier Rank
296 / 368Market Capitalization - BSEM ranking 259 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.